**India-UK Trade Pact Enhances Access for Medical Devices**
The recent India-UK trade agreement has introduced a mutual recognition agreement framework aimed at easing the entry of medical devices certified by Indian regulatory bodies into the UK market. This development, announced by an official on Tuesday, is expected to bolster the market presence of Indian manufacturers against global competitors such as China, Brazil, and Vietnam, who currently face non-preferential duties.
The free trade agreement allows medical devices certified by the Central Drugs Standard Control Organisation (CDSCO) or the Indian Certification of Medical Devices to enter the UK market with greater ease. Notably, medical devices and instruments will now be exported to the UK at zero tariffs, a significant reduction from the existing duty range of 2% to 6%. This change is particularly advantageous for Indian manufacturers of surgical and diagnostic equipment.
The UK medical devices market, valued at USD 32 billion in 2024, is projected to grow to USD 69 billion by 2035, with a compound annual growth rate (CAGR) of 7.19%. This growth presents a substantial opportunity for Indian medical device manufacturers.
Additionally, a bilateral regulatory cooperation framework is set to be established between CDSCO and the UK’s Medicines and Healthcare products Regulatory Agency (MHRA), potentially evolving into a Mutual Recognition Agreement. This agreement will include provisions for joint inspections, data sharing, harmonization of technical documentation, and training programs between Indian and UK regulators. Such collaboration aims to foster confidence in each other’s regulatory systems, thereby enhancing market access for Indian exports.
India is dedicated to achieving a fair and mutually beneficial agreement and is actively engaging with the UK to explore pathways for regulatory cooperation, including the recognition of CDSCO approvals. To prevent the routing of third-country goods through the UK into India, the comprehensive economic and trade agreement includes robust Rules of Origin. These rules define product origin and determine eligibility for preferential tariffs. The combination of stringent Rules of Origin, digital certificate of origin systems, and customs monitoring will ensure that only legitimate products made or significantly transformed in the FTA partner countries benefit from tariff concessions.
In conclusion, the India-UK trade pact represents a significant step forward for Indian medical device manufacturers, providing them with enhanced access to the lucrative UK market while fostering regulatory cooperation between the two nations.
**FAQ**
**What is the significance of the mutual recognition agreement in the India-UK trade pact?**
The mutual recognition agreement allows Indian medical devices certified by local regulatory bodies to enter the UK market more easily, reducing tariffs and enhancing market access for Indian manufacturers.
